gimli

GAUDIUMIVF stock AI analysis

GAUDIUMIVF Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers

GAUDIUM IVF N WOMEN H L is a small-cap stock in Healthcare. This Gimli page shows the latest available GAUDIUMIVF price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.

Analyze with AI Open interactive GAUDIUMIVF stock page

Price

₹107.93

1W return

+9.27%

1M return

-1.42%

3M return

-19.90%

6M return

-11.15%

1Y return

n/a

Market cap

₹785.59 cr

33.93

5.16

ROE

+23.31%

ROCE

+27.74%

RSI

53.62

Turnover

₹3.22 cr

Why it can matter in screens

Momentum: GAUDIUMIVF is below 50DMA, below 200DMA; RSI is 53.62.
Returns: 1D +2.17%, 1W +9.27%, 1M -1.42%, 3M -19.90%, 1Y n/a.
Trend levels: 52W high ₹163.18, 52W low ₹90.27, off high -33.86%.
Liquidity: latest turnover is ₹3.22 cr; volume vs 20D is +0.99%.
Valuation/profitability: PE 33.93, PB 5.16, ROE +23.31%, ROCE +27.74%.
Growth: 3Y sales CAGR +33.11%, 3Y profit CAGR +21.86%.

Quick Answers

What is the latest GAUDIUMIVF stock price?

The latest stored price for GAUDIUMIVF is Rs 107.93 as of 2026-11-03.

Is GAUDIUMIVF above its 50DMA and 200DMA?

GAUDIUMIVF is below 50DMA, below 200DMA. The latest 50DMA is 110.46 and the latest 200DMA is n/a.

What are GAUDIUMIVF PE, ROE and ROCE?

GAUDIUMIVF has PE 33.93, ROE +23.31%, and ROCE +27.74% in Gimli's latest available snapshot.

How has GAUDIUMIVF performed recently?

GAUDIUMIVF has returned -1.42% over 1 month, -19.90% over 3 months, and n/a over 12 months in the latest stored data.

Is this stock page investment advice?

No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.

Financials and Ownership

Quarterly income statement

Period	Revenue	EBITDA	PAT	EPS
2026-06-30	19.38 cr	3.55 cr	1.78 cr	0.25
2026-03-31	30.35 cr	12.35 cr	8.36 cr	1.34
2025-12-31	24.51 cr	6.65 cr	3.63 cr	0.50
2025-09-30	31.88 cr	13.91 cr	9.38 cr	nan
2025-06-30	17.76 cr	5.15 cr	3.08 cr	0.42
2025-03-31	26.92 cr	8.96 cr	6.46 cr	0.89
2024-12-31	14.42 cr	5.66 cr	3.40 cr	0.47

Annual income statement

Year	Revenue	EBITDA	PAT	EPS
2026-03-31	104.36 cr	38.24 cr	24.49 cr	3.92
2025-03-31	70.72 cr	28.87 cr	19.18 cr	2.63
2024-03-31	47.89 cr	19.54 cr	10.32 cr	1.42
2023-03-31	44.24 cr	20.09 cr	13.53 cr	1.86
2022-03-31	n/a	n/a	n/a	1.11

Balance sheet

Period	Assets	Cash	Debt	Equity
2026-03-31	193.10 cr	8.79 cr	24.57 cr	152.30 cr
2025-03-31	88.51 cr	7.21 cr	20.61 cr	46.30 cr
2024-03-31	51.01 cr	11.86 cr	17.40 cr	26.99 cr
2023-03-31	36.63 cr	15.06 cr	11.55 cr	22.73 cr

Cash flow

Period	OCF	FCF	Cash change
2026-03-31	7.25 cr	0.53 cr	n/a
2025-03-31	8.72 cr	-0.16 cr	n/a
2024-03-31	3.44 cr	0.65 cr	n/a
2023-03-31	23.85 cr	8.60 cr	n/a
2022-03-31	n/a	n/a	n/a

Shareholding Trend

Period	Promoter	FII/FPI	DII	MF	Retail	Pledge
2026-06-30	+71.29%	+3.02%	+2.22%	+0.00%	+23.47%	+0.00%
2026-03-31	+71.29%	+6.70%	+2.62%	+0.00%	+19.39%	+0.00%
2026-02-26	+71.29%	+9.24%	+5.11%	+0.00%	+14.36%	+0.00%

Industry Peers

Symbol	Name	Mcap	PE	ROE	1Y
SUNPHARMA	SUN PHARMACEUTICAL IND L	424,658.30 cr	35.053345	+15.50%	+3.72%
DIVISLAB	DIVI S LABORATORIES LTD	267,167.60 cr	91.684145	+18.37%	+47.91%
TORNTPHARM	TORRENT PHARMACEUTICALS L	157,377.11 cr	74.094685	+16.87%	+28.16%
LAURUSLABS	LAURUS LABS LIMITED	125,408.69 cr	114.827348	+21.77%	+138.16%
ZYDUSLIFE	ZYDUS LIFESCIENCES LTD	124,833.39 cr	27.818646	+16.04%	+26.46%
APOLLOHOSP	APOLLO HOSPITALS ENTER. L	121,354.29 cr	57.614911	+22.62%	+7.87%
DRREDDY	DR. REDDY S LABORATORIES	113,923.95 cr	40.698752	+7.80%	+14.41%
CIPLA	CIPLA LTD	112,841.65 cr	38.950805	+8.80%	-7.58%

Try these prompts

Analyze GAUDIUM IVF N WOMEN H L with valuation, momentum and industry peers
Compare GAUDIUMIVF with other Healthcare stocks
Show small-cap stocks in Healthcare above 50DMA with positive 1M return
Find Healthcare stocks with improving momentum and reasonable valuation

Related screen ideas

Data snapshot: 2026-11-03. Not investment advice.